BioTelemetry, Inc. Deferred Tax Assets, Net of Valuation Allowance
BioTelemetry, Inc. had Deferred Tax Assets, Net of Valuation Allowance of $55.30 million as of 2019-12-31, per its 10-K filed 2020-02-28.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance
us-gaap:DeferredTaxAssetsNet · last filed 2020-02-28
- 2019-12-31: Deferred Tax Assets, Net of Valuation Allowance $55.30M.
- 2018-12-31: Deferred Tax Assets, Net of Valuation Allowance $52.95M.
- 2017-12-31: Deferred Tax Assets, Net of Valuation Allowance $51.65M.
- 2016-12-31: Deferred Tax Assets, Net of Valuation Allowance $47.54M.
| Period end | Deferred Tax Assets, Net of Valuation Allowance |
|---|---|
| 2019-12-31 | $55.30M 10-K · filed 2020-02-28 |
| 2018-12-31 | $52.95M 10-K · filed 2020-02-28 |
| 2017-12-31 | $51.65M 10-K · filed 2019-02-22 |
| 2016-12-31 | $47.54M 10-K · filed 2018-02-27 |
| 2015-12-31 | $6.00M 10-K · filed 2017-02-22 |
| 2014-12-31 | $4.32M 10-K · filed 2016-02-22 |
| 2013-12-31 | $2.60M 10-K · filed 2015-02-23 |
| 2012-12-31 | $3.24M 10-K · filed 2014-02-26 |